Blood Cancer Applications
Our blood cancer product portfolio addresses the complete spectrum of hematological malignancies with innovative CAR and TCR solutions.
Leukemia related Products
Leukemia, generally refers to cancers of the WBCs. In America, more than forty thousand people are diagnosed with leukemia each year. It arises in the bone marrow, the soft, sponge-like material inside long bones of four limbs, where blood cells form. Our products target various leukemia subtypes through gene mutation and chromosome fraction rearrangement approaches. We offer solutions for ALL, AML, CLL, and CML subtypes with different growth rates and cell types affected.
Learn MoreLymphoma related Products
Lymphoma is a group of blood cancers that originates from cells of the lymph system. Our products address both Hodgkin lymphoma (10% of cases) and non-Hodgkin lymphoma (NHL - 90% of cases). We offer solutions targeting abnormal B lymphocytes, T-cells, and NK cells based on specific lymphoma subtypes classified by WHO including Hodgkin lymphoma, mature B cell neoplasms, mature T cell and NK cell neoplasms, and precursor lymphoid neoplasms.
Learn MoreSolid Tumor Applications
Our solid tumor solutions leverage advanced CAR and TCR technologies to target various epithelial and connective tissue malignancies.
Carcinoma related Products
Carcinoma is a kind of cancer derived from epithelial cells, beginning from cells of the skin or tissue lining the body's surfaces. Our CAR-modified T cells and NK cells target various carcinoma-specific antigens for diverse cancer types that are more common in adults. We offer solutions for renal cell carcinoma, melanoma, cervical carcinoma, lung malignancy, colorectal cancer, prostate cancer, breast cancer, and pancreatic cancer.
Learn MoreSarcoma related Products
Sarcomas are malignant tumors of connective tissues, including soft tissue sarcomas and bone sarcomas. Our innovative biological therapies activate the immune system's potential for treating various sarcoma subtypes, especially those diagnosed in children with genetic abnormalities or radiation exposure history. We offer products for osteosarcoma, Ewing's sarcoma, chondrosarcoma, rhabdomyosarcoma, synovial sarcoma, and GIST.
Learn MorePediatric Cancer Applications
Specialized solutions for childhood cancers, addressing unique challenges in pediatric oncology with age-appropriate therapeutic approaches.
Blastoma related Products
Blastoma is a general term for cancers that almost uniquely affect children, arising in precursor cells or blasts. These account for 25% of all malignant tumors in children younger than 15. Our products target various blastoma types originating from different body parts including brain, liver, kidneys, nervous system, bones and retina. We offer solutions for glioblastoma, osteoblastoma, hepatoblastoma, nephroblastoma, retinoblastoma, and neuroblastoma.
Learn MoreGerm Cell Tumor related Products
Germ cell tumors (GCT) are rare neoplasms arising from germ cells, accounting for 2-4% of childhood and adolescent cancers. Our products address both cancerous and benign GCTs that can metastasize to lungs, liver, lymph nodes, central nervous system, and bone marrow. We offer products for ovarian cancer and other germ cell tumor types.
Learn MoreNeurological Cancer Applications
Advanced solutions for brain and central nervous system tumors, utilizing targeted approaches to overcome blood-brain barrier challenges.
Glioma related Products
Gliomas are tumors occurring in the brain or spine, arising from glial cells. Our CAR products target glioma-specific antigens to assist development of new treatments. Products are designed based on histological features and location-specific symptoms including headaches, vomiting, seizures, and visual loss. We offer products for ependymoma, oligodendroglioma, brainstem glioma, and optic nerve glioma.
Learn MoreImmune Disorder Applications
Innovative approaches for autoimmune diseases and viral infections, leveraging precise immune modulation strategies.
Autoimmune Disease related Products
Autoimmune diseases affect up to 50 million Americans through abnormal immune responses to normal body substances. Our products offer novel treatments including cytokine blockade, T-cell and B-cell removal (including anti-CD20 therapy), and immunoglobulin-based approaches for over 80 types of autoimmune conditions affecting various organs.
Learn MoreViral Infection related Products
Our CAR products target viral antigens and viral-associated cancer antigens from Epstein–Barr virus (EBV), Cytomegalovirus (CMV), and Adenovirus (Adv). These solutions address viral infections associated with various cancers including Hodgkin's lymphoma, Burkitt's lymphoma, gastric cancer, and autoimmune diseases.
Learn More
